Vipivotide tetraxetan Ligand-Linker Conjugate - HY-43869
Nur noch %1 verfügbar
Catalog #
HY-43869
Ab
320,00 €
Vipivotide tetraxetan Ligand-Linker Conjugate (PSMA-617 Ligand-Linker Conjugate) is a complex composed of pharmacophore group Glutamate-urea-Lysine peptide coupling linker, which can be used to synthesize Vipivotide tetraxetan (PSMA-617). Glutamate-urea-Lysine selectively binds to prostate-specific membrane antigen (PSMA)[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-43869/Vipivotide-tetraxetan-Ligand-Linker-Conjugate-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | PSMA-617 Ligand-Linker Conjugate |
| CAS | 1703768-74-4 |
| Storage | -20°C, 3 years (Powder) |
| MWT | 655.74 |
| Solubility | DMSO : 125 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | ADC Linker |
| Application: | Cancer-programmed cell death |
|---|